Needham Maintains Buy on Boston Scientific, Raises Price Target to $61
Portfolio Pulse from richadhand@benzinga.com
Needham analyst Mike Matson maintains a 'Buy' rating on Boston Scientific (NYSE:BSX) and raises the price target from $57 to $61.
July 28, 2023 | 8:35 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Mike Matson maintains a 'Buy' rating on Boston Scientific and raises the price target from $57 to $61.
The raised price target by Needham indicates a positive outlook for Boston Scientific. This could potentially lead to an increase in the stock price in the short term as it signals confidence in the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100